Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immune-response and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant - A Prospective, Controlled, Multicenter Cohort Study by the RECOVAC Consortium

NCT04741386 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04741386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04741386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immune-response and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant - A Prospective, Controlled, Multicenter Cohort Study by the RECOVAC Consortium
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
February 17, 2021
Completion date
February 25, 2022
Enrollment
854 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, covid19